Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial

Slotman, B.J., Faivre-Finn, C., van Tinteren, H. et al. (12 more authors) (2017) Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial. Lung Cancer, 108. pp. 150-153. ISSN 0169-5002

Metadata

Authors/Creators:
  • Slotman, B.J.
  • Faivre-Finn, C.
  • van Tinteren, H.
  • Keijserd, A.
  • Praag, J.
  • Knegjens, J.
  • Hatton, M.
  • van Dam, I.
  • van der Leest, A.
  • Reymen, B.
  • Stigt, J.
  • Haslett, K.
  • Tripathi, D.
  • Smit, E.F.
  • Senan, S.
Copyright, Publisher and Additional Information: © 2017 The Author(s). Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Thoracic radiotherapy; Extensive stage; Small cell lung cancer; Metastases
Dates:
  • Accepted: 17 March 2017
  • Published (online): 21 March 2017
  • Published: June 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 22 Dec 2017 11:12
Last Modified: 22 Dec 2017 11:12
Published Version: https://doi.org/10.1016/j.lungcan.2017.03.007
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.lungcan.2017.03.007
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)